Trial Profile
Phase I Study to Determine the Maximum Tolerated Dose of NC-6004 in Patients with Solid Tumours
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 09 Jul 2017
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors NanoCarrier
- 24 May 2011 New trial record